Vernal Biosciences Funding: $43M Raised, Series A (2023)

Vernal Biosciences funding overview

Vernal Biosciences is based in Burlington, VT. Vernal Biosciences has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2023. The round record for Vernal Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Ampersand Capital Partners, Charles River Labs, Dynamk Capital, Vermont Center for Emerging Technologies. 4 distinct backers are named across the disclosed rounds.

Vernal Biosciences at a glance

Total raised: $43M
Latest round: Series A
Latest round date: June 2023
Headquarters: Burlington, VT
Notable investors: Ampersand Capital Partners, Charles River Labs, Dynamk Capital, Vermont Center for Emerging Technologies

Frequently asked about Vernal Biosciences funding

How much has Vernal Biosciences raised?: Vernal Biosciences has raised $43M in total disclosed funding across the rounds on record.
Who has invested in Vernal Biosciences?: Ampersand Capital Partners, Charles River Labs, Dynamk Capital, Vermont Center for Emerging Technologies are named among the investors backing Vernal Biosciences.
What was the latest Vernal Biosciences funding round?: The most recent disclosed round is a Series A, announced in June 2023.
Where is Vernal Biosciences based?: Vernal Biosciences is based in Burlington, VT.
When did Vernal Biosciences last raise?: The last disclosed Vernal Biosciences round closed in June 2023 at Series A.

Vernal Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlington below to benchmark round size and investor mix.

Vernal Biosciences Funding: $43M Raised, Series A (2023)

Vernal Biosciences funding overview

Vernal Biosciences at a glance

Frequently asked about Vernal Biosciences funding

Companies related to Vernal Biosciences (19)

Browse related funding lists (3)